Foster & Motley’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.5M | Buy |
160,338
+5,585
| +4% | +$149K | 0.23% | 106 |
|
|
2025
Q4 | $3.85M | Buy |
154,753
+14,670
| +10% | +$370K | 0.21% | 113 |
|
|
2025
Q3 | $3.57M | Sell |
140,083
-1,834
| -1% | -$45.3K | 0.19% | 121 |
|
|
2025
Q2 | $3.44M | Buy |
141,917
+21,246
| +18% | +$495K | 0.2% | 120 |
|
|
2025
Q1 | $3.06M | Sell |
120,671
-2,262
| -2% | -$59.2K | 0.19% | 124 |
|
|
2024
Q4 | $3.26M | Sell |
122,933
-22,368
| -15% | -$607K | 0.21% | 112 |
|
|
2024
Q3 | $4.21M | Sell |
145,301
-12,747
| -8% | -$372K | 0.27% | 96 |
|
|
2024
Q2 | $4.42M | Sell |
158,048
-9,431
| -6% | -$260K | 0.3% | 90 |
|
|
2024
Q1 | $4.65M | Sell |
167,479
-20,075
| -11% | -$557K | 0.32% | 86 |
|
|
2023
Q4 | $5.4M | Sell |
187,554
-9,797
| -5% | -$296K | 0.4% | 66 |
|
|
2023
Q3 | $6.55M | Sell |
197,351
-11,683
| -6% | -$413K | 0.54% | 43 |
|
|
2023
Q2 | $7.67M | Sell |
209,034
-14,796
| -7% | -$576K | 0.59% | 34 |
|
|
2023
Q1 | $9.13M | Sell |
223,830
-7,831
| -3% | -$338K | 0.74% | 23 |
|
|
2022
Q4 | $11.9M | Sell |
231,661
-3,424
| -1% | -$164K | 1.01% | 17 |
|
|
2022
Q3 | $10.3M | Buy |
235,085
+1,570
| +0.7% | +$76.3K | 0.98% | 15 |
|
|
2022
Q2 | $12.2M | Sell |
233,515
-2,179
| -0.9% | -$111K | 1.08% | 14 |
|
|
2022
Q1 | $12.2M | Sell |
235,694
-3,633
| -2% | -$189K | 0.96% | 21 |
|
|
2021
Q4 | $14.1M | Sell |
239,327
-9,266
| -4% | -$459K | 1.1% | 16 |
|
|
2021
Q3 | $10.7M | Sell |
248,593
-866
| -0.3% | -$38.4K | 0.89% | 23 |
|
|
2021
Q2 | $9.77M | Buy |
249,459
+1,558
| +0.6% | +$60.6K | 0.82% | 26 |
|
|
2021
Q1 | $8.98M | Sell |
247,901
-194
| -0.1% | -$6.89K | 0.75% | 30 |
|
|
2020
Q4 | $9.13M | Sell |
248,095
-1,489
| -0.6% | -$54.6K | 0.88% | 25 |
|
|
2020
Q3 | $8.69M | Sell |
249,584
-9,074
| -4% | -$318K | 1.02% | 20 |
|
|
2020
Q2 | $8.03M | Buy |
258,658
+1,279
| +0.5% | +$43.5K | 1% | 21 |
|
|
2020
Q1 | $7.97M | Sell |
257,379
-10,248
| -4% | -$349K | 1.19% | 17 |
|
|
2019
Q4 | $9.95M | Sell |
267,627
-5,237
| -2% | -$187K | 1.25% | 18 |
|
|
2019
Q3 | $9.3M | Sell |
272,864
-4,076
| -1% | -$148K | 1.27% | 19 |
|
|
2019
Q2 | $11.4M | Sell |
276,940
-1,629
| -0.6% | -$64.7K | 1.6% | 11 |
|
|
2019
Q1 | $11.2M | Buy |
278,569
+4,511
| +2% | +$181K | 1.62% | 12 |
|
|
2018
Q4 | $11.3M | Sell |
274,058
-2,579
| -0.9% | -$107K | 1.82% | 10 |
|
|
2018
Q3 | $11.6M | Sell |
276,637
-6,068
| -2% | -$234K | 1.74% | 9 |
|
|
2018
Q2 | $9.73M | Buy |
282,705
+1,744
| +0.6% | +$59.6K | 1.55% | 15 |
|
|
2018
Q1 | $9.46M | Sell |
280,961
-10,955
| -4% | -$377K | 1.54% | 16 |
|
|
2017
Q4 | $10M | Sell |
291,916
-6,147
| -2% | -$210K | 1.6% | 14 |
|
|
2017
Q3 | $10.1M | Sell |
298,063
-12,871
| -4% | -$414K | 1.74% | 12 |
|
|
2017
Q2 | $9.91M | Sell |
310,934
-3,962
| -1% | -$125K | 1.75% | 13 |
|
|
2017
Q1 | $10.2M | Buy |
314,896
+10,014
| +3% | +$316K | 1.86% | 10 |
|
|
2016
Q4 | $9.39M | Buy |
304,882
+18,024
| +6% | +$550K | 1.8% | 9 |
|
|
2016
Q3 | $9.22M | Buy |
286,858
+33,816
| +13% | +$1.13M | 1.78% | 9 |
|
|
2016
Q2 | $8.45M | Buy |
253,042
+8,546
| +3% | +$273K | 1.67% | 11 |
|
|
2016
Q1 | $6.88M | Buy |
244,496
+41,745
| +21% | +$1.19M | 1.39% | 23 |
|
|
2015
Q4 | $6.21M | Buy |
202,751
+5,226
| +3% | +$164K | 1.32% | 26 |
|
|
2015
Q3 | $5.89M | Sell |
197,525
-6,904
| -3% | -$221K | 1.34% | 23 |
|
|
2015
Q2 | $6.5M | Sell |
204,429
-23,806
| -10% | -$776K | 1.43% | 19 |
|
|
2015
Q1 | $7.53M | Sell |
228,235
-8,386
| -4% | -$267K | 1.65% | 18 |
|
|
2014
Q4 | $6.99M | Sell |
236,621
-4,759
| -2% | -$136K | 1.58% | 19 |
|
|
2014
Q3 | $6.77M | Buy |
241,380
+9,468
| +4% | +$266K | 1.57% | 20 |
|
|
2014
Q2 | $6.53M | Buy |
231,912
+8,445
| +4% | +$241K | 1.51% | 23 |
|
|
2014
Q1 | $6.81M | Buy |
223,467
+19,890
| +10% | +$593K | 1.67% | 19 |
|
|
2013
Q4 | $5.92M | Buy |
203,577
+2,208
| +1% | +$64.3K | 1.49% | 22 |
|
|
2013
Q3 | $5.49M | Buy |
201,369
+652
| +0.3% | +$17.7K | 1.46% | 23 |
|
|
2013
Q2 | $5.33M | Buy |
+200,717
| New | +$5.55M | 1.48% | 25 |
|
Other funds holding PFE
VCM
VPM
Foster & Motley's PFE Position: Q1 2026 in Review
Foster & Motley increased its Pfizer (PFE) stake by 3.6% in Q1 2026, buying an estimated $149K and bringing the position to 160,338 shares worth $4.5M. The position accounts for 0.23% of the portfolio, ranked #106.
Foster & Motley first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.1M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Foster & Motley held 160,338 shares of Pfizer worth $4.5M as of Q1 2026.
- Foster & Motley bought 5,585 Pfizer shares in Q1 2026, an estimated $149K.
- Pfizer made up 0.23% of Foster & Motley's portfolio in Q1 2026, its #106 holding.
- Foster & Motley first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Foster & Motley's Pfizer position peaked at $14.1M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.